Page last updated: 2024-09-02

3-chloro-L-tyrosine and deoxycytidine

3-chloro-L-tyrosine has been researched along with deoxycytidine in 1 studies

Compound Research Comparison

Studies
(3-chloro-L-tyrosine)
Trials
(3-chloro-L-tyrosine)
Recent Studies (post-2010)
(3-chloro-L-tyrosine)
Studies
(deoxycytidine)
Trials
(deoxycytidine)
Recent Studies (post-2010) (deoxycytidine)
8112618,1604,6528,898

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dedon, PC; Fox, JG; Kang, P; Knutson, CG; Korzenik, JR; Liberman, RG; Lu, K; Mangerich, A; Prestwich, EG; Raczynski, AR; Tannenbaum, SR; Wishnok, JS; Wogan, GN; Ye, W; Zeng, Y1

Other Studies

1 other study(ies) available for 3-chloro-L-tyrosine and deoxycytidine

ArticleYear
Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Jun-25, Volume: 110, Issue:26

    Topics: Acute-Phase Proteins; Animals; Biomarkers; Chemokines; Cytokines; Deoxycytidine; Disease Models, Animal; DNA Damage; DNA-Binding Proteins; Female; Helicobacter hepaticus; Helicobacter Infections; Humans; Immunity, Innate; Inflammatory Bowel Diseases; Male; Mice; Mice, Knockout; Tyrosine

2013